| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |